KR20200103380A - Phosphine oxide compound and organic light emitting element comprising the same - Google Patents
Phosphine oxide compound and organic light emitting element comprising the same Download PDFInfo
- Publication number
- KR20200103380A KR20200103380A KR1020190021765A KR20190021765A KR20200103380A KR 20200103380 A KR20200103380 A KR 20200103380A KR 1020190021765 A KR1020190021765 A KR 1020190021765A KR 20190021765 A KR20190021765 A KR 20190021765A KR 20200103380 A KR20200103380 A KR 20200103380A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- unsubstituted
- layer
- compound
- Prior art date
Links
- -1 Phosphine oxide compound Chemical class 0.000 title claims abstract description 47
- 150000001875 compounds Chemical class 0.000 claims description 55
- 230000032258 transport Effects 0.000 claims description 23
- 239000011368 organic material Substances 0.000 claims description 18
- 238000002347 injection Methods 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 230000005525 hole transport Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 7
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000004306 triazinyl group Chemical group 0.000 claims description 4
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 82
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 48
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 44
- 239000000543 intermediate Substances 0.000 description 43
- 238000006243 chemical reaction Methods 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 239000002904 solvent Substances 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 230000000052 comparative effect Effects 0.000 description 26
- 239000000463 material Substances 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 23
- 239000012044 organic layer Substances 0.000 description 17
- 238000004440 column chromatography Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 239000012153 distilled water Substances 0.000 description 14
- 238000000605 extraction Methods 0.000 description 14
- 238000007872 degassing Methods 0.000 description 12
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 10
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 9
- 229940125898 compound 5 Drugs 0.000 description 9
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 229940125904 compound 1 Drugs 0.000 description 6
- 229940125773 compound 10 Drugs 0.000 description 6
- 229940125782 compound 2 Drugs 0.000 description 6
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 6
- 150000002894 organic compounds Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940126214 compound 3 Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 4
- 238000005137 deposition process Methods 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000005283 ground state Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- 125000005561 phenanthryl group Chemical group 0.000 description 2
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- XJKSTNDFUHDPQJ-UHFFFAOYSA-N 1,4-diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=C(C=2C=CC=CC=2)C=C1 XJKSTNDFUHDPQJ-UHFFFAOYSA-N 0.000 description 1
- WSNKEJIFARPOSQ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(1-benzothiophen-2-ylmethyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC3=C(S2)C=CC=C3)C=CC=1 WSNKEJIFARPOSQ-UHFFFAOYSA-N 0.000 description 1
- ODJZWBLNJKNOJK-UHFFFAOYSA-N Brc(cc1)cc2c1ccc(Br)c2 Chemical compound Brc(cc1)cc2c1ccc(Br)c2 ODJZWBLNJKNOJK-UHFFFAOYSA-N 0.000 description 1
- HVNFDSNMCPJOHM-UHFFFAOYSA-N Brc1c(cccc2)c2c(-c2cc3cc([O](c4ccccc4)c4ccccc4)ccc3cc2)c2c1cccc2 Chemical compound Brc1c(cccc2)c2c(-c2cc3cc([O](c4ccccc4)c4ccccc4)ccc3cc2)c2c1cccc2 HVNFDSNMCPJOHM-UHFFFAOYSA-N 0.000 description 1
- CPLVRQCGZGZQBJ-UHFFFAOYSA-N C=[O](Cc(cc1)ccc1-c(c1c2cccc1)c(cccc1)c1c2Br)(c1ccccc1)c1ccccc1 Chemical compound C=[O](Cc(cc1)ccc1-c(c1c2cccc1)c(cccc1)c1c2Br)(c1ccccc1)c1ccccc1 CPLVRQCGZGZQBJ-UHFFFAOYSA-N 0.000 description 1
- NZTBACVVLACPNL-UHFFFAOYSA-N CC1(C)OB(c2cc(-c3ccc(c(cccc4)c4c4ccccc44)c4c3)ccc2)OC1(C)C Chemical compound CC1(C)OB(c2cc(-c3ccc(c(cccc4)c4c4ccccc44)c4c3)ccc2)OC1(C)C NZTBACVVLACPNL-UHFFFAOYSA-N 0.000 description 1
- ZLKGGEBOALGXJZ-UHFFFAOYSA-N COc1cccc2c1nccc2 Chemical compound COc1cccc2c1nccc2 ZLKGGEBOALGXJZ-UHFFFAOYSA-N 0.000 description 1
- QPVFMEFJFFQONP-UHFFFAOYSA-N Cc(cc1)cc2c1ccc(Br)c2 Chemical compound Cc(cc1)cc2c1ccc(Br)c2 QPVFMEFJFFQONP-UHFFFAOYSA-N 0.000 description 1
- XRTYCQJIGJDGLZ-UHFFFAOYSA-N Cl[O](c1ccccc1)c1ccccc1 Chemical compound Cl[O](c1ccccc1)c1ccccc1 XRTYCQJIGJDGLZ-UHFFFAOYSA-N 0.000 description 1
- JFJZWYFLPUVOOI-UHFFFAOYSA-N O[O](c1ccccc1)(c1ccccc1)c(cc1)ccc1-c1c(cccc2)c2c(-c2cc(-c(cc3)cc4c3c3ccccc3c3c4cccc3)ccc2)c2c1cccc2 Chemical compound O[O](c1ccccc1)(c1ccccc1)c(cc1)ccc1-c1c(cccc2)c2c(-c2cc(-c(cc3)cc4c3c3ccccc3c3c4cccc3)ccc2)c2c1cccc2 JFJZWYFLPUVOOI-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- VOZBMWWMIQGZGM-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(-c(cc2)ccc2-c(cc2)cc3c2c(-c2cc4ccccc4cc2)c(cccc2)c2c3-c2cc3ccccc3cc2)nc2c1cccc2 Chemical compound c(cc1)ccc1-[n]1c(-c(cc2)ccc2-c(cc2)cc3c2c(-c2cc4ccccc4cc2)c(cccc2)c2c3-c2cc3ccccc3cc2)nc2c1cccc2 VOZBMWWMIQGZGM-UHFFFAOYSA-N 0.000 description 1
- XGRJZXREYAXTGV-UHFFFAOYSA-N chlorodiphenylphosphine Chemical compound C=1C=CC=CC=1P(Cl)C1=CC=CC=C1 XGRJZXREYAXTGV-UHFFFAOYSA-N 0.000 description 1
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical compound C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6521—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- H01L51/0067—
-
- H01L51/0072—
-
- H01L51/5012—
-
- H01L51/5072—
-
- H01L51/5092—
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
- H10K50/171—Electron injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
본 발명은 포스핀옥사이드 화합물 및 이를 포함하는 유기발광소자에 관한 것이다.The present invention relates to a phosphine oxide compound and an organic light emitting device comprising the same.
유기발광소자(organic light emitting diode, OLED)는 최근 평판 디스플레이(flat panel display)의 수요가 증가함에 따라 주목 받고 있다. 일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛 에너지로 전환시켜주는 현상을 말한다.Organic light emitting diodes (OLEDs) are attracting attention as the demand for flat panel displays increases in recent years. In general, the organic light emission phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material.
이러한 유기발광소자는 유기발광재료에 전류를 가하여 전기에너지를 빛으로 전환시키는 소자로서 통상 양극(anode)과 음극(cathode) 사이에 기능성 유기물 층이 삽입된 구조로 이루어져 있다. 여기서 유기물층은 유기발광소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 정공차단층, 전자수송층, 전자주입층 등으로 이루어질 수 있다.Such an organic light-emitting device is a device that converts electrical energy into light by applying an electric current to an organic light-emitting material, and has a structure in which a functional organic material layer is inserted between an anode and a cathode. Here, the organic material layer is often made of a multilayer structure composed of different materials in order to increase the efficiency and stability of the organic light emitting device.For example, the organic material layer is composed of a hole injection layer, a hole transport layer, a light emitting layer, a hole blocking layer, an electron transport layer, an electron injection layer, etc. I can.
이러한 유기발광소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공(hole)이, 음극에서는 전자(electron)가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만나 재결합(recombination)에 의해 에너지가 높은 여기자를 형성하게 된다. 이때 형성된 여기자가 다시 바닥상태(ground state)로 이동하면서 특정한 파장을 갖는 빛이 발생하게 된다.In the structure of such an organic light emitting device, when a voltage is applied between the two electrodes, holes from the anode and electrons from the cathode are injected into the organic material layer, and the injected holes and electrons meet and recombination. High-energy excitons are formed. At this time, the formed excitons move back to the ground state, and light having a specific wavelength is generated.
최근에는, 형광 발광물질뿐 아니라 인광 발광물질도 유기발광소자의 발광물질로 사용될 수 있음이 알려졌으며 이러한 인광 발광은 바닥상태에서 여기상태(excited state)로 전자가 전이한 후, 계간 전이(intersystem crossing)를 통해 단일항 여기자가 삼중항 여기자로 비발광 전이된 다음, 삼중항 여기자가 바닥상태로 전이하면서 발광하는 메카니즘으로 이루어진다.Recently, it has been known that not only a fluorescent light emitting material but also a phosphorescent light emitting material can be used as a light emitting material of an organic light emitting device, and this phosphorescent light emission is performed after electrons are transferred from a ground state to an excited state, and then intersystem crossing. ) Through the singlet excitons to the triplet excitons, and then the triplet excitons to the ground state, and the light emission is composed of a mechanism.
본 발명의 목적은 새로운 구조의 포스핀옥사이드 화합물 및 이를 포함하는 유기발광소자를 제공하는 것이다.It is an object of the present invention to provide a new structure of a phosphine oxide compound and an organic light emitting device comprising the same.
본 발명의 다른 목적은 구동전압이 낮고 고효율 및 장기 수명 등의 특성을 가지는 유기발광소자용 화합물을 제공하는 것이다.Another object of the present invention is to provide a compound for an organic light emitting device having characteristics such as low driving voltage and high efficiency and long life.
또한, 상기 유기발광소자용 화합물을 포함하는 화상표시장치를 제공하는 것이다.In addition, it is to provide an image display device including the compound for an organic light emitting device.
본 발명의 목적은 하기 화학식 1로 표시되는 포스핀옥사이드 화합물에 의해 달성된다.The object of the present invention is achieved by a phosphine oxide compound represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에서, L1 및 L2는 각각 독립적으로 페닐렌기 또는 나프탈렌기이고, Ar1은 치환 또는 비치환된 C5-C30 아릴기, 및 치환 또는 비치환된 C5-C30 헤테로아릴기로 이루어진 군으로부터 선택된다.In Formula 1, L 1 and L 2 are each independently a phenylene group or a naphthalene group, and Ar 1 is a substituted or unsubstituted C5-C30 aryl group, and a substituted or unsubstituted C5-C30 heteroaryl group. Is selected.
상기 Ar1은 치환 또는 비치환된 페닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 벤조이미다졸릴기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 스피로비플루오레닐기 및 이들의 조합으로 이루어진 군으로부터 선택될 수 있다.Ar 1 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted phenanthrolinyl group, a substituted or unsubstituted benzoimidazolyl group, a substituted or unsubstituted triphenylenyl group, It may be selected from the group consisting of a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted spirobifluorenyl group, and combinations thereof.
또한, 본 발명의 목적은 제1전극, 제2전극, 및 상기 제1전극과 제2전극 사이에 위치하는 1층 이상의 유기물층을 포함하며, 상기 유기물층 중 1층 이상은 본 발명에 따른 포스핀옥사이드 화합물을 포함하는 유기발광소자에 의해 달성된다.It is also an object of the present invention to include a first electrode, a second electrode, and one or more organic material layers positioned between the first and second electrodes, and at least one of the organic material layers is a phosphine oxide according to the present invention. It is achieved by an organic light-emitting device comprising a compound.
상기 유기물층은 발광층, 정공주입층, 정공수송층, 및 정공주입 및 정공수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하고, 상기 적어도 1개의 층은 본 발명에 따른 포스핀옥사이드 화합물을 포함할 수 있다.The organic material layer includes at least one layer selected from the group consisting of a light emitting layer, a hole injection layer, a hole transport layer, and a layer simultaneously injecting and transporting holes, and the at least one layer is a phosphine oxide compound according to the present invention. It may include.
상기 유기물층은 발광층, 전자주입층, 전자수송층, 및 전자주입 및 전자수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하고, 상기 적어도 1개의 층은 본 발명에 따른 포스핀옥사이드 화합물을 포함할 수 있다.The organic material layer includes at least one layer selected from the group consisting of a light emitting layer, an electron injection layer, an electron transport layer, and a layer that simultaneously injects and transports electrons, and the at least one layer is the phosphine oxide compound according to the present invention. It may include.
상기 유기물층은 적어도 하나의 전하생성층(Charge Generation Layer: CGL)을 포함하고, 상기 적어도 1개의 층은 본 발명에 따른 포스핀옥사이드 화합물을 포함할 수 있다.The organic material layer may include at least one charge generation layer (CGL), and the at least one layer may include the phosphine oxide compound according to the present invention.
본 발명에 따르면 새로운 구조의 포스핀옥사이드 화합물이 제공된다.According to the present invention, a new structure of a phosphine oxide compound is provided.
본 발명의 신규한 포스핀옥사이드 화합물은 유기발광소자 제작 시 수반되는 증착 과정에서 유기물의 열안정성뿐만 아니라 적용되는 유기발광소자의 낮은 구동전압, 높은 효율, 고휘도 및 장수명을 유도할 수 있다.The novel phosphine oxide compound of the present invention can induce not only thermal stability of the organic material during the deposition process accompanying the fabrication of the organic light emitting device, but also low driving voltage, high efficiency, high brightness, and long lifespan of the applied organic light emitting device.
도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다.1 is a cross-sectional view of an organic light emitting device according to an embodiment of the present invention.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예들은 본 발명의 개시가 완전하도록 하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다. Advantages and features of the present invention, and a method of achieving them will become apparent with reference to embodiments described below in detail. However, the present invention is not limited to the embodiments disclosed below, but will be implemented in various forms different from each other, and only these embodiments make the disclosure of the present invention complete, and common knowledge in the technical field to which the present invention pertains. It is provided to completely inform the scope of the invention to those who have it, and the invention is only defined by the scope of the claims.
도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 도시된 것이며, 본 발명이 도시된 구성의 크기 및 두께에 반드시 한정되는 것은 아니다.The size and thickness of each component shown in the drawings are illustrated for convenience of description, and the present invention is not limited to the size and thickness of the illustrated component.
이하, 첨부된 도면을 참조하여 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
본 발명에 따른 포스핀옥사이드 화합물은 하기 화학식 1로 표시된다.The phosphine oxide compound according to the present invention is represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에서, In Formula 1,
L1 및 L2는 각각 독립적으로 페닐렌기 또는 나프탈렌기이고, L 1 and L 2 are each independently a phenylene group or a naphthalene group,
Ar1은 치환 또는 비치환된 C5-C30 아릴기 또는 치환 또는 비치환된 C5-C30 헤테로아릴기로 이루어진 군으로부터 선택된다.Ar 1 is selected from the group consisting of a substituted or unsubstituted C5-C30 aryl group or a substituted or unsubstituted C5-C30 heteroaryl group.
상기 Ar1에 치환될 수 있는 치환기로는 비한정적으로 페닐기, 나프틸기, 안트라세닐기, 페난트릴기, m-바이페닐일기, p-바이페닐일기 p-터페닐기, m-터페닐기, 트리페닐레닐기, 트리아졸일기, 피리딘기, 피리미딘기, 카바졸기를 들 수 있다.Substituents that may be substituted for Ar 1 include, but are not limited to, phenyl group, naphthyl group, anthracenyl group, phenanthryl group, m-biphenylyl group, p-biphenylyl group, p-terphenyl group, m-terphenyl group, triphenyl Renyl group, triazolyl group, pyridine group, pyrimidine group, and carbazole group are mentioned.
구체적으로, 본 발명의 일 구현예에서, 치환 또는 비치환된 탄소수 5 내지 30 아릴기 및 또는 치환 또는 비치환된 탄소수 5 내지 30 헤테로아릴기는, 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트릴기, 치환 또는 비치환된 나프타세닐기, 치환 또는 비치환된 피레닐기, 치환 또는 비치환된 바이페닐일기, 치환 또는 비치환된 p-터페닐기, 치환 또는 비치환된 m-터페닐기, 치환 또는 비치환된 크리세닐기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 페릴레닐기, 치환 또는 비치환된 인데닐기, 치환 또는 비치환된 퓨라닐기, 치환 또는 비치환된 티오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 피라졸릴기, 치환 또는 비치환된 이미다졸일기, 치환 또는 비치환된 트리아졸일기, 치환 또는 비치환된 옥사졸일기, 치환 또는 비치환된 티아졸일기, 치환 또는 비치환된 옥사디아졸일기, 치환 또는 비치환된 티아디아졸일기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 벤조퓨라닐기, 치환 또는 비치환된 벤조티오페닐기, 치환 또는 비치환된 벤조이미다졸일기, 치환 또는 비치환된 인돌일기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 나프티리디닐기, 치환 또는 비치환된 벤즈옥사진일기, 치환 또는 비치환된 벤즈티아진일기, 치환 또는 비치환된 아크리디닐기, 치환 또는 비치환된 페나진일기, 치환 또는 비치환된 페노티아진일기, 치환 또는 비치환된 페녹사진일기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 스피로비플루오레닐기 또는 이들의 조합일 수 있으나, 이에 제한되지는 않는다.Specifically, in one embodiment of the present invention, a substituted or unsubstituted C5 to C30 aryl group and or a substituted or unsubstituted C5 to C30 heteroaryl group is a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphth Tyl group, substituted or unsubstituted anthracenyl group, substituted or unsubstituted phenanthryl group, substituted or unsubstituted naphthacenyl group, substituted or unsubstituted pyrenyl group, substituted or unsubstituted biphenylyl group, substituted or unsubstituted P-terphenyl group, substituted or unsubstituted m-terphenyl group, substituted or unsubstituted chrysenyl group, substituted or unsubstituted triphenylenyl group, substituted or unsubstituted perylenyl group, substituted or unsubstituted Nyl group, substituted or unsubstituted furanyl group, substituted or unsubstituted thiophenyl group, substituted or unsubstituted pyrrolyl group, substituted or unsubstituted pyrazolyl group, substituted or unsubstituted imidazolyl group, substituted or unsubstituted tria Zolyl group, substituted or unsubstituted oxazolyl group, substituted or unsubstituted thiazolyl group, substituted or unsubstituted oxadiazolyl group, substituted or unsubstituted thiadiazolyl group, substituted or unsubstituted pyridyl group, substituted Or an unsubstituted pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted benzofuranyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted benzo Imidazolyl group, substituted or unsubstituted indolyl group, substituted or unsubstituted quinolinyl group, substituted or unsubstituted isoquinolinyl group, substituted or unsubstituted quinazolinyl group, substituted or unsubstituted quinoxalinyl group, substituted Or unsubstituted naphthyridinyl group, substituted or unsubstituted benzoxazineyl group, substituted or unsubstituted benzthiazinyl group, substituted or unsubstituted acridinyl group, substituted or unsubstituted phenazineyl group, substituted or unsubstituted A phenothiazinyl group, a substituted or unsubstituted phenoxazineyl group, a substituted or unsubstituted phenanthrolinyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted spirobifluorenyl group, or a combination thereof. , But is not limited thereto.
바람직하게는, 상기 Ar1은 치환 또는 비치환된 페닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 벤조이미다졸릴기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 스피로비플루오레닐기 및 이들의 조합으로 이루어진 군으로부터 선택될 수 있다.Preferably, Ar 1 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted phenanthrolinyl group, a substituted or unsubstituted benzoimidazolyl group, a substituted or unsubstituted tree Phenylenyl group, substituted or unsubstituted pyridyl group, substituted or unsubstituted pyrimidinyl group, substituted or unsubstituted triazinyl group, substituted or unsubstituted spirobifluorenyl group, and combinations thereof I can.
구체적인 예를 들어, 본 발명에 따른 포스핀옥사이드 화합물은 하기 표시되는 화합물일 수 있다.For a specific example, the phosphine oxide compound according to the present invention may be a compound represented below.
본 발명에 따른 포스핀옥사이드 화합물을 하기 화학식 2를 통해 좀더 구체적으로 설명할 수 있다.The phosphine oxide compound according to the present invention can be described in more detail through the following Formula 2.
[화학식 2][Formula 2]
높은 효율의 유기발광소자를 안정적으로 만들기 위해서는 물질간의 밴드갭(band gap)과 에너지 레벨(energy level)이 적정 수준을 가져야 한다. 또한 유기화합물은 고온에서 변성이 나타나지 않아야 소자의 지속적이고 안정된 구동이 가능하다.In order to make a high-efficiency organic light-emitting device stable, a band gap and energy level between materials must have an appropriate level. In addition, organic compounds must not exhibit denaturation at high temperatures to enable continuous and stable driving of the device.
본 발명에 따른 상기 화학식으로 표시되는 포스핀옥사이드 화합물은 안트라센을 중심으로 L1 또는 L2에 페닐렌 또는 나프탈렌을 도입하여 전자이동도(electron mobility)가 높아질 수 있도록 설계되었다.The phosphine oxide compound represented by the above formula according to the present invention is designed to increase electron mobility by introducing phenylene or naphthalene into L 1 or L 2 centered on anthracene.
좀더 구체적으로 설명하자면, 본 발명의 화합물에 포스핀 구조를 도입함으로써 열적 안정성 및 전기적 안정성을 향상시킬 수 있으며, 본 발명의 화합물이 적용된 소자는 안정적인 구동을 통해 수명이 향상되게 된다. 또한, 상기 포스핀옥사이드의 P 원자에 페닐렌 또는 나프탈렌을 도입하여 화합물의 입체 구조에 대한 영향 없이 밴드 레벨을 발광층에 적절한 수준으로 유지할 수 있으며, 이로써 전자의 이동을 용이하게 할 수 있다. 하지만, 분자 내부에 페닐기 또는 나프탈렌만 있는 경우 LUMO 값이 낮아 발광층과의 에너지 장벽이 커지게 되기 때문에 분자 내 전기이동도가 높고 LUMO 값을 올려줄 수 있는 안트라센을 도입하여 전자 발광층 에너지 레벨에 맞춤으로써 전자 이동을 용이하게 할 수 있다. 이와 더불어, 본 발명의 포스핀옥사이드 화합물은 상기 화학식 내 Ar에 전자가 풍부한 작용기가 적용되어 더욱더 높은 전자이동도를 가질 수 있다. 결과적으로, 본 발명에 따른 포스핀옥사이드 화합물은 적용되는 유기발광소자의 높은 효율 및 낮은 구동전압을 유도할 수 있다.In more detail, thermal stability and electrical stability can be improved by introducing a phosphine structure into the compound of the present invention, and the lifespan of the device to which the compound of the present invention is applied is improved through stable driving. In addition, by introducing phenylene or naphthalene into the P atom of the phosphine oxide, the band level can be maintained at an appropriate level in the light emitting layer without affecting the three-dimensional structure of the compound, thereby facilitating the movement of electrons. However, if there is only phenyl group or naphthalene in the molecule, the LUMO value is low, so the energy barrier with the light emitting layer increases, so by introducing anthracene that has high intramolecular electrical mobility and can increase the LUMO value, it is adjusted to the energy level of the electron emitting layer. Electron movement can be facilitated. In addition, the phosphine oxide compound of the present invention may have a higher electron mobility by applying an electron-rich functional group to Ar in the above formula. As a result, the phosphine oxide compound according to the present invention can induce high efficiency and low driving voltage of the applied organic light emitting device.
일반적인 유기 발광 소자를 제작하는 방법은 물질을 용해시켜 만드는 프린팅 공정과 물질에 고온을 가하여 승화시켜 만드는 증착 공정이 있다. 현재 대표적으로 쓰이는 방법은 증착공정이며, 이러한 증착공정을 적용한 유기발광소자의 대량 생산 시 생산성을 극대화하기 위해 롤투롤(roll to roll) 방식을 사용하게 되는데 이때 도가니의 온도가 유기물질의 승화되는 보다 높은 온도를 유지하게 된다. 이러한 이유로 제품군이 될 수 있는 소자의 수율을 극대화하기 위해서는 화합물이 고온의 온도를 장시간 유지하더라도 변성이 없어야 한다.A general method of manufacturing an organic light-emitting device includes a printing process made by dissolving a material and a deposition process made by sublimating a material by applying high temperature. Currently, the most commonly used method is the deposition process, and a roll to roll method is used to maximize productivity when mass production of organic light emitting devices applied with this deposition process is applied. At this time, the temperature of the crucible is lower than that of the organic material. It will maintain a high temperature. For this reason, in order to maximize the yield of a device that can be a product family, even if the compound maintains a high temperature for a long time, it must not be denatured.
본 발명의 포스핀옥사이드 화합물은 하기 화학식 3과 같이 링커 부분(L)에 수소결합을 할 수 있는 작용기를 도입하는 구조로서, 이러한 구조로 인해 본 발명의 화합물은 입체적인 구조가 안정되어 향상된 열안정성을 가질 수 있다. The phosphine oxide compound of the present invention is a structure in which a functional group capable of hydrogen bonding is introduced into the linker moiety (L) as shown in Formula 3 below, and due to this structure, the compound of the present invention stabilizes the three-dimensional structure and provides improved thermal stability. Can have.
[화학식 3][Formula 3]
전자 수송층의 경우 전자의 이동 효율을 증가시키기 위해 전자가 비편제화 되어 있는 구조를 적용을 한다. 하지만 Ar 그룹에 페닐을 사용하게 되면 전자가 풍부하기로 알려진 방향족 탄화수소(Polycyclic Aromatic Hydrocarbon, PAH)에 비해 비편제화되는 정도가 적어 전자 아동의 효율성이 떨어지게 된다. 또한, 증착 시 높은 온도를 유기 화합물에 가하게 되는데 상기 화학식 3을 보면 기존에 알려진 페릴렌 작용기(69.2℃) 보다 높은 녹는점을 가지고 있어 더욱더 유기 화합물의 열적 안정성을 가지게 된다.In the case of the electron transport layer, a structure in which electrons are deorganized is applied to increase the efficiency of electrons. However, when phenyl is used for the Ar group, the degree of deorganization is less than that of polycyclic aromatic hydrocarbons (PAH), which are known to be rich in electrons, and thus the efficiency of electron children is reduced. In addition, a high temperature is applied to the organic compound during deposition. As shown in Chemical Formula 3, since it has a melting point higher than that of a previously known perylene functional group (69.2°C), it has more thermal stability of the organic compound.
이와 더불어, Ar 그룹에 헤테로아릴기를 적용하게 되면 유기 화합물에 불포화 결합을 가진 부분이 없게 된다. 그로 인해 유기화합의 공명 효과가 증가되어 화합물의 안정성이 및 전기적인 특성이 개선되는 효과를 얻을 수 있다.In addition, when a heteroaryl group is applied to the Ar group, there is no portion having an unsaturated bond in the organic compound. As a result, the resonance effect of the organic compound is increased, so that the stability and electrical properties of the compound are improved.
[화학식 4] [Formula 4]
상기 화학식 4와 같이 분자 내 수소결합을 가지게 되면 유기발광소자 제작 시 수소결합을 가지지 못하는 기존의 유기화합물보다 전압효율이 향상되게 된다. 즉, 본 발명의 포스핀옥사이드 화합물은 링커에 입체장애가 적은 페닐렌 또는 나프탈렌이 도입되어 있거나 Ar에 수소결합을 할 수 있는 작용기가 도입된 구조로서 이러한 화합물이 적용된 유기발광소자의 전압효율을 향상시킬 수 있다.When hydrogen bonds are present in the molecule as in Chemical Formula 4, voltage efficiency is improved compared to conventional organic compounds that do not have hydrogen bonds when manufacturing an organic light emitting device. That is, the phosphine oxide compound of the present invention is a structure in which phenylene or naphthalene having less steric hindrance is introduced into the linker, or a functional group capable of hydrogen bonding to Ar is introduced, and the voltage efficiency of the organic light emitting device to which such compound is applied can be improved. I can.
도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다. 도 1을 참조하면, 유기발광소자(1)는 탄뎀형 구조로서 제1전극(양극, 110), 제2전극(음극, 120), 제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)을 포함한다.1 is a cross-sectional view of an organic light emitting device according to an embodiment of the present invention. Referring to FIG. 1, the organic light-emitting device 1 has a tandem type structure, with a first electrode (anode, 110), a second electrode (cathode, 120), a first light-emitting
제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)은 유기물층으로서 제1전극(110)과 제2전극(120) 사이에 위치하며, 제1전하생성층(240)은 제1발광부(210)와 제2발광부(220) 사이에 위치하고, 제2전하생성층(250)은 제2발광부(220)와 제3발광부(230)사이에 위치한다.The first
제1발광부(210)는 정공주입층(211), 제1정공수송층(212), 제1발광층(213), 제1전자수송층(214)으로 이루어져 있으며, 제2발광부(220)는 제2정공수송층(221), 제2발광층(222) 및 제2전자수송층(223)으로 이루어져 있고, 제3발광부(230)는 제3정공수송층(231), 제3발광층(232), 제3전자수송층(233) 및 전자주입층(234)으로 이루어져 있다.The first
제1전하생성층(240)은 n형 전하생성층(241)과 p형 전하생성층(242)으로 이루어져 있으며, 제2전하생성층(250)은 n형 전하생성층(251)과 p형 전하생성층(252)으로 이루어져 있다. n형 전하생성층(241, 251)은 알칼리 금속으로 도핑되어 있을 수 있다.The first
본 발명에 따른 포스핀옥사이드 화합물은 제1전자수송층(214), 제2전자수송층(223), 제3전자수송층(233), 전자주입층(234), 제1전하생성층(240) 및/또는 제2전하생성층(250)에 포함되어 사용될 수 있으며, 특히 n형 전하생성층(241, 251)에 사용될 수 있다.The phosphine oxide compound according to the present invention comprises a first
설명한 유기발광소자(1)는 다양하게 변형가능하다. 일부 유기층은 생략되거나 추가될 수 있으며, 텐덤형태가 아닐 수 있으며, 2개 또는 4개 이상의 발광층을 가지는 텐덤형태일 수도 있다. 또한, 유기발광소자(1)는 전자수송과 전자주입을 동시에 하는 층을 포함하는 유기층을 포함할 수 있으며, 이러한 경우에도 본 발명에 따른 페난트롤린 화합물이 사용될 수 있다.The described organic light emitting device 1 can be variously modified. Some organic layers may be omitted or added, may not be in a tandem form, and may be in a tandem form having two or four or more emission layers. Further, the organic light-emitting device 1 may include an organic layer including a layer that simultaneously transports electrons and injects electrons, and even in this case, the phenanthroline compound according to the present invention may be used.
이하에서는 본 발명에 따른 포스핀옥사이드 화합물의 제조예 및 유기발광소자의 실시예 및 비교예를 설명한다. 다만, 하기에 기재된 제조예 및 실시예는 본 발명을 구체적으로 예시하거나 설명하기 위한 것일 뿐이며, 이하에 기재된 제조예 및 실시예에 의해 본 발명을 제한하여 해석해서는 안된다.Hereinafter, examples and comparative examples of the preparation of the phosphine oxide compound and the organic light emitting device according to the present invention will be described. However, the preparation examples and examples described below are for illustrative purposes only, and should not be interpreted as limiting the present invention by the preparation examples and examples described below.
실시예Example
중간체의 합성Synthesis of intermediates
중간체 A-1의 합성예Synthesis Example of Intermediate A-1
2구 둥근 바닥 플라스크에 중간체 B-1(100 g, 0.28 mol)과 중간체 B-2(74.6 g, 0.336 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(115.9 g, 0.84 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(9.7 g, 3 %w/w)를 첨가하고, 4 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. Methylene chloride 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 A-1를 95 g(75%) 얻었다.Intermediate B-1 (100 g, 0.28 mol) and Intermediate B-2 (74.6 g, 0.336 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (115.9 g, 0.84 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (9.7 g, 3% w/w) was added and refluxed for 4 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using a methylene chloride solvent to obtain 95 g (75%) of compound A-1.
중간체 A-2의 합성예Synthesis Example of Intermediate A-2
2구 둥근 바닥 플라스크에 중간체 A-1(80 g, 0.17 mol)과 화합물 NBS(N-Bromosuccinimide)(37.45 g, 0.21 mol)을 DMF(Dimethylformamide)에 녹이고, 1 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 석출된 고체를 여과하여 화합물 A-2로서 83.41 g(89%)을 얻었다.Intermediate A-1 (80 g, 0.17 mol) and compound NBS (N-Bromosuccinimide) (37.45 g, 0.21 mol) were dissolved in DMF (Dimethylformamide) and refluxed for 1 hour in a 2-neck round bottom flask. The reaction was terminated by adding an excess of water, and the precipitated solid was filtered to give 83.41 g (89%) as compound A-2.
중간체 A-3 의 합성예Synthesis Example of Intermediate A-3
2구 둥근 바닥 플라스크에 중간체 B-1(50 g, 0.14 mol)과 중간체 B-2(37.3 g, 0.168 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(57.5 g, 0.42 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(4.35 g, 3 %w/w)를 첨가하고, 3 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. Methylene chloride 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 A-3로서 43 g(69%)을 얻었다.Intermediate B-1 (50 g, 0.14 mol) and Intermediate B-2 (37.3 g, 0.168 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (57.5 g, 0.42 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (4.35 g, 3 %w/w) was added and refluxed for 3 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using a methylene chloride solvent to give 43 g (69%) as compound A-3.
중간체 A-4의 합성예 Synthesis Example of Intermediate A-4
2구 둥근 바닥 플라스크에 중간체 A-3(40 g, 0.08 mol)과 화합물 NBS(18.7 g, 0.105 mol)을 DMF에 녹이고, 1 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 석출된 고체를 여과하여 화합물 A-4로서 38.73 g(91%)을 얻었다.Intermediate A-3 (40 g, 0.08 mol) and compound NBS (18.7 g, 0.105 mol) were dissolved in DMF in a two necked round bottom flask and refluxed for 1 hour. The reaction was terminated by adding an excess of water, and the precipitated solid was filtered to obtain 38.73 g (91%) as compound A-4.
중간체 A-5의 합성예 Synthesis Example of Intermediate A-5
N2 치환된 플라스크에 무수 THF 200 ml와 중간체 B-4(20 g, 70 mmol)을 넣은 뒤 -78℃를 유지하면서 n-BuLi 28 ml를 적하하여 첨가하였다. 1h 교반후 chlorodiphenylphosphine(14.02 g, 64 mmol)을 THF 200ml에 용해하여 적하 후 실온에서 12 시간 동안 교반하였다. 반응액을 EA 400 ml와 물 100 ml 5회 추출 후 유기층을 무수 MgSO4로 건조하고 H2O2를 과량 투입 후 회전식 증발기를 이용하여 용매를 제거하였다. MC용매를 사용하여 컬럼크로마토그래피로 분리하여 중간체 A-5로서 19 g(73%)을 얻었다.After adding 200 ml of anhydrous THF and intermediate B-4 (20 g, 70 mmol) to a flask substituted with N 2 , 28 ml of n-BuLi was added dropwise while maintaining -78°C. After stirring for 1 h, chlorodiphenylphosphine (14.02 g, 64 mmol) was dissolved in 200 ml of THF, added dropwise, and stirred at room temperature for 12 hours. The reaction solution was extracted 5 times with 400 ml of EA and 100 ml of water, and the organic layer was dried over anhydrous MgSO 4 , and an excessive amount of H 2 O 2 was added, and the solvent was removed using a rotary evaporator. Separated by column chromatography using an MC solvent to obtain 19 g (73%) as Intermediate A-5.
중간체 A-6의 합성예Synthesis Example of Intermediate A-6
3구 둥근 바닥 플라스크에 톨루엔과 에탄올을 투입 후 중간체 A-5(19 g, 24.56 mol)과 중간체 B-2(10.36 g, 51.32 mmol)을 넣고 교반하였다. 증류수에 K2CO3(9.67 g, 69.98 mmol)을 녹인 후 반응액에 첨가하였다. N2 치환 후 Pd(PPh3)4(1.6 g, 1.5 %w/w)를 가하고 11 시간 동안 환류하였다. 반응을 종결하고 methylene chloride 500 ml와 물 500 ml 3회로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/EA(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 중간체 A-6로서 21 g(89%)을 얻었다.Toluene and ethanol were added to a three necked round bottom flask, and then Intermediate A-5 (19 g, 24.56 mol) and Intermediate B-2 (10.36 g, 51.32 mmol) were added and stirred. After dissolving K 2 CO 3 (9.67 g, 69.98 mmol) in distilled water, it was added to the reaction solution. After N 2 substitution, Pd(PPh 3 ) 4 (1.6 g, 1.5 %w/w) was added and refluxed for 11 hours. After the reaction was terminated, extraction was performed three times with 500 ml of methylene chloride and 500 ml of water. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/EA (100/1, v/v) solvent to obtain 21 g (89%) as Intermediate A-6.
중간체 A-7의 합성예Synthesis Example of Intermediate A-7
2구 둥근 바닥 플라스크에 중간체 A-6(21 g, 41.62 mmol)과 화합물 NBS(8.89 g, 49.95 mmol)을 DMF에 녹이고, 1 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 석출된 고체를 여과하여 중간체 A-7로서 20 g(82%)을 얻었다.Intermediate A-6 (21 g, 41.62 mmol) and compound NBS (8.89 g, 49.95 mmol) were dissolved in DMF in a two necked round bottom flask and refluxed for 1 hour. The reaction was terminated by adding an excess of water, and the precipitated solid was filtered to obtain 20 g (82%) as an intermediate A-7.
화합물 1의 제조예Preparation Example of Compound 1
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-3(9.79 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹인다. 증류수에 K2CO3(7.46 g, 0.054 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.62g, 3%w/w)를 가하고, 4 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v)용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 1을 6.5 g(48%)얻었다.In a two neck round bottom flask, Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-3 (9.79 g, 0.022 mol) are well dissolved in toluene and ethanol. After dissolving K 2 CO 3 (7.46 g, 0.054 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.62g, 3%w/w) was added and refluxed for 4 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. After separation by column chromatography using MC/MEOH (100/1, v/v) solvent, 6.5 g (48%) of compound 1 was obtained.
화합물 2의 제조예Preparation example of compound 2
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-4(9.63 g, 0.021 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3 %w/w)를 가하고 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/EA(10/1, v/v)용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 1로서 7.67 g(56%)을 얻었다.Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-4 (9.63 g, 0.021 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3 %w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/EA (10/1, v/v) solvent to obtain 7.67 g (56%) as compound 1.
화합물 3의 제조예Preparation Example of Compound 3
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)와 중간체 B-5(6.09 g, 0.0216 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3 %w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/EA(10/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 3로서 5.69 g(52%)을 얻었다.Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-5 (6.09 g, 0.0216 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3 %w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/EA (10/1, v/v) solvent to obtain 5.69 g (52%) as compound 3.
화합물 4의 제조예Preparation example of compound 4
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-6(10.48 g, 0.0216 mol)을 톨루엔과 에탄올에 잘 녹인다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3 %w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/EA(10/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 4로서 6.86 g(47%)을 얻었다.In a two neck round bottom flask, Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-6 (10.48 g, 0.0216 mol) are well dissolved in toluene and ethanol. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3 %w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/EA (10/1, v/v) solvent to obtain 6.86 g (47%) as compound 4.
화합물 5의 제조예Preparation example of compound 5
2구 둥근 바닥 플라스크에 중간체 A-3(10 g, 0.018 mol)과 중간체 B-3(9.79 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3%w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 5로서 8.49 g(62%)을 얻었다.Intermediate A-3 (10 g, 0.018 mol) and Intermediate B-3 (9.79 g, 0.022 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3% w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/MEOH (100/1, v/v) solvent to obtain 8.49 g (62%) as compound 5.
화합물 6의 제조예Preparation example of compound 6
2구 둥근 바닥 플라스크에 중간체 A-3(10 g, 0.018 mol)과 중간체 B-8(9.79 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3%w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 6으로서 8.6 g(61%)을 얻었다.Intermediate A-3 (10 g, 0.018 mol) and Intermediate B-8 (9.79 g, 0.022 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3% w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/MEOH (100/1, v/v) solvent to obtain 8.6 g (61%) as compound 6.
화합물 7의 제조예Preparation example of compound 7
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-9(9.79 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3%w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 7로서 8.22 g(60%)을 얻었다.Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-9 (9.79 g, 0.022 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3% w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/MEOH (100/1, v/v) solvent to obtain 8.22 g (60%) as compound 7.
화합물 8의 제조예Preparation Example of Compound 8
3구 둥근 바닥 플라스크에 톨루엔과 에탄올을 투입 후 중간체 A-7(14 g, 24 mmol)과 중간체 B-10(6.77 g, 24 mmol)을 넣고 교반하였다. 증류수에 K2CO3(4.97 g, 36 mmol)을 녹인 후 반응액에 첨가하였다. N2 치환 후 Pd(PPh3)4(0.41 g, 1.5 %w/w)를 가하고, 11시간 동안 환류하였다. 반응을 종결하고 methylene chloride 500 ml와 물 500 ml 3회로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/EA(100/50, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 8(10 g, 63%) 얻었다.Toluene and ethanol were added to a three necked round bottom flask, and then Intermediate A-7 (14 g, 24 mmol) and Intermediate B-10 (6.77 g, 24 mmol) were added and stirred. After dissolving K 2 CO 3 (4.97 g, 36 mmol) in distilled water, it was added to the reaction solution. After N 2 substitution, Pd(PPh 3 ) 4 (0.41 g, 1.5 %w/w) was added and refluxed for 11 hours. After the reaction was terminated, extraction was performed three times with 500 ml of methylene chloride and 500 ml of water. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/EA (100/50, v/v) solvent to obtain compound 8 (10 g, 63%).
화합물 9의 제조예Preparation Example of Compound 9
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-11(7.97 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3 %w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 9으로서 9.13 g(73%)을 얻었다.Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-11 (7.97 g, 0.022 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3 %w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/MEOH (100/1, v/v) solvent to obtain 9.13 g (73%) as compound 9.
화합물 10의 제조예Preparation Example of Compound 10
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-12(7.7 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3 %w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 10로서 11.1 g(82%)을 얻었다.Intermediate A-2 (10 g, 0.018 mol) and Intermediate B-12 (7.7 g, 0.022 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3 %w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/MEOH (100/1, v/v) solvent to give 11.1 g (82%) as compound 10.
화합물 11의 제조예Preparation Example of Compound 11
2구 둥근 바닥 플라스크에 중간체 A-2(10 g, 0.018 mol)과 중간체 B-14(9.42 g, 0.022 mol)을 톨루엔과 에탄올에 잘 녹였다. 증류수에 K2CO3(7.40 g, 0.052 mol)을 녹인 후 반응액에 첨가하였다. 탈기체화한 다음 Pd(PPh3)4(0.59 g, 3 %w/w)를 가하고, 11 시간 동안 환류하였다. 과량의 물을 가하여 반응을 종결하고 methylene chloride로 추출하였다. 유기층을 무수 MgSO4로 건조하고 회전식 증발기를 이용하여 용매를 제거하였다. MC/MEOH(100/1, v/v) 용매를 사용하여 컬럼크로마토그래피로 분리하여 화합물 11로서 10.07 g(74%)을 얻었다.Intermediate A-2 (10 g, 0.018 mol) and intermediate B-14 (9.42 g, 0.022 mol) were well dissolved in toluene and ethanol in a two necked round bottom flask. After dissolving K 2 CO 3 (7.40 g, 0.052 mol) in distilled water, it was added to the reaction solution. After degassing, Pd(PPh 3 ) 4 (0.59 g, 3 %w/w) was added and refluxed for 11 hours. The reaction was terminated by adding an excess of water, followed by extraction with methylene chloride. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Separated by column chromatography using MC/MEOH (100/1, v/v) solvent to obtain 10.07 g (74%) as compound 11.
하기 표 1은 합성된 물질들의 1H NMR과 MASS/FAB을 나타낸다. 상기 1H NMR 분석 결과에서 사용된 약자 중 s는 단일선, d는 이중선, t는 삼중선, g는 사중선, m은 다중선을 의미한다.Table 1 shows the 1 H NMR and MASS / FAB of the composite material. Among the abbreviations used in the 1 H NMR analysis result, s is a singlet, d is a doublet, t is a triplet, g is a quartet, and m is a multiplet.
본 발명자는 하기 화학식 5의 화합물과 같이 안트라센에 별도의 링커 없이 물질이 도입되는 경우 입체적인 장애가 생겨 물질의 열안정성이 떨어지는 것을 예상하였으며 아래 실험 결과를 통해 확인하였다. 비교화합물 1 내지 6은 각각 하기 화학식 5의 구조에 해당 Ar1을 적용하여 진행하였다.The present inventors predicted that when a substance was introduced into the anthracene without a separate linker, such as the compound of Formula 5 below, a steric hindrance occurred and the thermal stability of the substance was degraded, and it was confirmed through the experimental results below. Comparative Compounds 1 to 6 were each carried out by applying the corresponding Ar 1 to the structure of Formula 5.
[화학식 5][Formula 5]
하기 표 2는 물질이 승화되는 온도보다 50℃ 올려서 5일 동안 진공 상태에서 온도를 유지한 유기물의 HPLC 결과이다.Table 2 below shows the HPLC results of organic substances in which the temperature was maintained in a vacuum state for 5 days by raising the temperature by 50° C. above the temperature at which the material was sublimated.
위 표의 결과를 보면 안트라센에 별도의 링커 없이 작용기가 도입된 비교화합물 1 내지 6의 HPLC 결과보다 페닐렌 또는 나프탈렌이 링커로 도입된 화합물 1 내지 11의 결과가 화합물의 변성이 적게 나타나는 것을 확인할 수 있으며 이를 통해 종래 알려진 포스핀옥사이드가 도입된 안트라센 화합물 보다 화합물의 열적 안정성이 크게 향상되었음을 알 수 있다.Looking at the results in the table above, it can be seen that the results of compounds 1 to 11 in which phenylene or naphthalene was introduced as a linker showed less denaturation than the HPLC results of Comparative Compounds 1 to 6 in which a functional group was introduced without a separate linker to anthracene. Through this, it can be seen that the thermal stability of the compound is significantly improved than that of the anthracene compound into which the previously known phosphine oxide is introduced.
유기발광소자의 제조Manufacturing of organic light emitting device
1. 비교예 a의 제조예1. Preparation Example of Comparative Example a
발광면적이 2 mm × 2 mm 크기가 되도록 ITO 기판을 패터닝한 후, 이소프로필 알코올과 UV 오존으로 각각 세정을 실시하였다. 이후, ITO기판을 진공 증착 장치의 기판 홀더에 장착하고 진공도가 1 × 10-7 torr가 되도록 압력을 잡았다. 이후 N2 분위기 하에 플라즈마 처리를 3 분간 하였다.After patterning the ITO substrate so that the luminous area was 2 mm × 2 mm in size, each was cleaned with isopropyl alcohol and UV ozone. Thereafter, the ITO substrate was mounted on the substrate holder of the vacuum evaporation apparatus, and the pressure was held so that the degree of vacuum was 1 × 10 -7 torr. After that, plasma treatment was performed for 3 minutes under an N 2 atmosphere.
그리고 먼저, HAT-CN 화합물을 진공 증착하여 5 nm 두께로 형성하였다. 이 화합물은 정공주입층으로 작용한다. 이 위에 제 1 정공수송층으로 NPB 물질을 50 nm 두께로 형성하였다. 이어서 제 2 정공수송층으로 HT-1 물질을 10 nm 두께로 형성하였다.And first, the HAT-CN compound was vacuum-deposited to form a thickness of 5 nm. This compound acts as a hole injection layer. On this, an NPB material was formed with a thickness of 50 nm as a first hole transport layer. Subsequently, the HT-1 material was formed to a thickness of 10 nm as a second hole transport layer.
이후 GH-1물질을 호스트로, GD-1물질을 도판트로 약 10% 질량비가 되도록 30 nm의 두께로 공증착하여 녹색 발광층을 형성하였다. Thereafter, a green light emitting layer was formed by co-depositing a GH-1 material as a host and a GD-1 material as a dopant to a thickness of about 10% at a thickness of 30 nm.
이 발광층위에 ET-1 화합물과 Liq 물질을 5:5 비율로 35 nm를 증착하여 전자수송층을 형성하였다. 이후 LiF 물질을 증착하여 1 nm 두께로 전자주입층을 형성하였다. 이후, Al을 100nm 두께로 증착시켜 음극을 형성하여 유기 EL 소자를 제작하였다.An electron transport layer was formed by depositing 35 nm of an ET-1 compound and a Liq material at a ratio of 5:5 on the emission layer. Thereafter, a LiF material was deposited to form an electron injection layer with a thickness of 1 nm. Thereafter, Al was deposited to a thickness of 100 nm to form a cathode to fabricate an organic EL device.
2. 비교예 b의 제조예2. Preparation Example of Comparative Example b
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 비교화합물 5로 바꾸어 유기발광소자를 제작하였다.In the same manner as in Comparative Example a described above, only the electron transport layer material was changed to Comparative Compound 5 to produce an organic light emitting device.
3. 실시예 1의 제조예3. Preparation Example of Example 1
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 1로 바꾸어 유기발광소자를 제작하였다.In the same manner as in Comparative Example a described above, only the electron transport layer material was changed to Compound 1 to produce an organic light emitting device.
4. 실시예 2의 제조예4. Preparation Example of Example 2
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 2로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was manufactured in the same manner as in Comparative Example a described above, but only the electron transport layer material was changed to Compound 2.
5. 실시예 3의 제조예5. Preparation Example of Example 3
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 4로 바꾸어 유기발광소자를 제작하였다.In the same manner as in Comparative Example a described above, only the electron transport layer material was changed to Compound 4 to produce an organic light-emitting device.
6. 실시예 4의 제조예6. Preparation Example of Example 4
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 5로 바꾸어 유기발광소자를 제작하였다.In the same manner as in Comparative Example a described above, but only the electron transport layer material was changed to Compound 5 to produce an organic light emitting device.
7. 실시예 5의 제조예7. Preparation Example of Example 5
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 6로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was manufactured in the same manner as in Comparative Example a described above, but only the electron transport layer material was changed to Compound 6.
8. 실시예 6의 제조예8. Preparation Example of Example 6
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 9로 바꾸어 유기발광소자를 제작하였다.In the same manner as in Comparative Example a described above, only the electron transport layer material was changed to Compound 9 to produce an organic light-emitting device.
9. 실시예 7의 제조예9. Preparation Example of Example 7
위에 전술한 비교예 a와 동일하게 구성하되, 전자수송층 물질만 화합물 10로 바꾸어 유기발광소자를 제작하였다.In the same manner as in Comparative Example a described above, but only the electron transport layer material was changed to Compound 10 to produce an organic light emitting device.
본 발명의 실시예 1 내지 7, 및 비교예 a 및 b에 의해 제조된 유기발광소자에 10 mA/cm2의 정전류를 가하여 포토리서치(photoresearch)사의 PR-670으로 발광 특성을 측정하였다.A constant current of 10 mA/cm 2 was applied to the organic light-emitting devices prepared according to Examples 1 to 7, and Comparative Examples a and b of the present invention, and the luminescence characteristics were measured with PR-670 of photoresearch.
이하에는 상기 실시예 1 내지 7 및 비교예 a 및 b의 유기발광소자의 구동전류, 구동전압, 전류효율 및 외부양자효율을 측정하여 이하의 표 3에 나타내었다.Hereinafter, the driving current, driving voltage, current efficiency, and external quantum efficiency of the organic light-emitting devices of Examples 1 to 7 and Comparative Examples a and b were measured and shown in Table 3 below.
J(mA/cm2)Driving current
J(mA/cm 2 )
(Voltage)Driving voltage
(Voltage)
(cd/A)Current efficiency
(cd/A)
(%)EQE
(%)
상기 표 3으로부터 실시예 1 내지 7의 유기발광소자의 구동전압, 전류효율, 외부양자효율은 비교예 a 및 b의 유기발광소자의 구동전압, 전류효율, 외부양자효율에 비하여 우수함을 확인할 수 있다.From Table 3, it can be seen that the driving voltage, current efficiency, and external quantum efficiency of the organic light emitting devices of Examples 1 to 7 are superior to the driving voltage, current efficiency, and external quantum efficiency of the organic light emitting devices of Comparative Examples a and b. .
본 발명은 반드시 이러한 실시예로 국한되는 것은 아니고, 본 발명의 기술사상을 벗어나지 않는 범위 내에서 다양하게 변형 실시될 수 있다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 그러므로, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The present invention is not necessarily limited to these embodiments, and various modifications may be made without departing from the spirit of the present invention. Accordingly, the embodiments disclosed in the present invention are not intended to limit the technical idea of the present invention, but to explain the technical idea, and the scope of the technical idea of the present invention is not limited by these embodiments. Therefore, it should be understood that the embodiments described above are illustrative and non-limiting in all respects. The scope of protection of the present invention should be interpreted by the following claims, and all technical ideas within the scope equivalent thereto should be interpreted as being included in the scope of the present invention.
Claims (7)
[화학식 1]
상기 화학식 1에서,
L1 및 L2는 각각 독립적으로 페닐렌기 또는 나프탈렌기이고,
Ar1은 치환 또는 비치환된 C5-C30 아릴기 및 치환 또는 비치환된 C5-C30 헤테로아릴기로 이루어진 군으로부터 선택된다.Phosphine oxide compound represented by the following formula 1:
[Formula 1]
In Formula 1,
L 1 and L 2 are each independently a phenylene group or a naphthalene group,
Ar 1 is selected from the group consisting of a substituted or unsubstituted C5-C30 aryl group and a substituted or unsubstituted C5-C30 heteroaryl group.
The phosphine oxide compound according to claim 1, wherein the compound represented by Formula 1 is selected from the group consisting of compounds represented below:
제2전극, 및
상기 제1전극과 제2전극 사이에 위치하는 1층 이상의 유기물층을 포함하며,
상기 유기물층 중 1층 이상은 제1항 내지 제3항 중 어느 한 항에 따른 포스핀옥사이드 화합물을 포함하는 유기발광소자.First electrode,
A second electrode, and
It includes at least one organic material layer positioned between the first electrode and the second electrode,
At least one of the organic material layers is an organic light-emitting device comprising the phosphine oxide compound according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190021765A KR20200103380A (en) | 2019-02-25 | 2019-02-25 | Phosphine oxide compound and organic light emitting element comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190021765A KR20200103380A (en) | 2019-02-25 | 2019-02-25 | Phosphine oxide compound and organic light emitting element comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200103380A true KR20200103380A (en) | 2020-09-02 |
Family
ID=72469414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190021765A KR20200103380A (en) | 2019-02-25 | 2019-02-25 | Phosphine oxide compound and organic light emitting element comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200103380A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114507254A (en) * | 2020-11-17 | 2022-05-17 | 上海和辉光电股份有限公司 | Compound and application thereof |
WO2022124858A1 (en) * | 2020-12-11 | 2022-06-16 | 솔루스첨단소재 주식회사 | Organic compound and organic electroluminescent device comprising same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100846221B1 (en) | 2007-04-03 | 2008-07-15 | 주식회사 진웅산업 | Light-emitting compound and organic light-emitting diodes using the same |
-
2019
- 2019-02-25 KR KR1020190021765A patent/KR20200103380A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100846221B1 (en) | 2007-04-03 | 2008-07-15 | 주식회사 진웅산업 | Light-emitting compound and organic light-emitting diodes using the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114507254A (en) * | 2020-11-17 | 2022-05-17 | 上海和辉光电股份有限公司 | Compound and application thereof |
WO2022124858A1 (en) * | 2020-12-11 | 2022-06-16 | 솔루스첨단소재 주식회사 | Organic compound and organic electroluminescent device comprising same |
KR20220083447A (en) * | 2020-12-11 | 2022-06-20 | 솔루스첨단소재 주식회사 | Organic compound and organic electroluminescent device comprising the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102040226B1 (en) | Organic light emitting device | |
KR101719173B1 (en) | Organic electroluminescent element | |
CN111747938B (en) | Arylamine compound and organic electroluminescent device thereof | |
JP7119204B2 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20180068861A (en) | Hetero-cyclic compound and organic light emitting device comprising the same | |
KR101940694B1 (en) | Heterocyclic compound and organic light emitting device containing the same | |
JPWO2018173598A1 (en) | Organic electroluminescent device | |
KR102136381B1 (en) | Novel hetero-cyclic compound and organic light emitting device comprising the same | |
KR20140058017A (en) | Novel heterocyclic compound for organic light emitting device and organic light emitting device comprising the same | |
CN107257787B (en) | Heterocyclic compound and organic light-emitting element comprising same | |
JP5683763B1 (en) | Benzopyridindole derivatives and organic electroluminescence devices | |
CN112106218A (en) | Organic light emitting diode | |
KR20130079890A (en) | Novel compound and organic light emitting device containing same | |
KR20190007892A (en) | Novel compound and organic electroluminescent divice including the same | |
KR20130010133A (en) | Heterocyclic compound, organic light-emitting diode comprising the same and flat display device | |
KR102054397B1 (en) | Hetero-cyclic compound and organic light emitting device comprising the same | |
KR20140050388A (en) | Compound for organic light emitting device and organic light emitting device comprising the same | |
KR101968213B1 (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR20140083622A (en) | Arylamine compound and organic light emitting device comprising same | |
KR20200103380A (en) | Phosphine oxide compound and organic light emitting element comprising the same | |
KR102362847B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102633652B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20200088772A (en) | Novel compound and organic light emitting device comprising the same | |
CN112805845A (en) | Compound having azabenzoxazole ring structure and organic electroluminescent element | |
KR101612158B1 (en) | Organic compounds and organic electro luminescence device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal |